11/5
04:57 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David
Neutral
Report
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David
11/5
04:51 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M
11/5
04:49 pm
antx
Form 3 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David
Low
Report
Form 3 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David
11/5
04:06 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Nov 04
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Nov 04
8/28
04:02 pm
antx
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: Octagon Capital Advisors LP
Neutral
Report
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: Octagon Capital Advisors LP
8/19
06:08 am
antx
Form 8-A12B AN2 Therapeutics, Inc.
Low
Report
Form 8-A12B AN2 Therapeutics, Inc.
8/19
06:05 am
antx
Form 8-K AN2 Therapeutics, Inc. For: Aug 15
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Aug 15
8/15
05:40 pm
antx
Form 144 AN2 Therapeutics, Inc. Filed by: RA Capital Healthcare Fund LP
Low
Report
Form 144 AN2 Therapeutics, Inc. Filed by: RA Capital Healthcare Fund LP
8/15
05:35 pm
antx
Form 144 AN2 Therapeutics, Inc. Filed by: RA Capital Nexus Fund II, L.P.
Low
Report
Form 144 AN2 Therapeutics, Inc. Filed by: RA Capital Nexus Fund II, L.P.
8/14
09:01 pm
antx
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: BML Investment Partners, L.P.
Medium
Report
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: BML Investment Partners, L.P.
8/14
08:24 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Aug 14 Filed by: Leonard Braden Michael
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Aug 14 Filed by: Leonard Braden Michael
8/13
05:40 pm
antx
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SC 13G/A AN2 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
8/13
05:04 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Aug 09 Filed by: Shah Rajeev M.
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Aug 09 Filed by: Shah Rajeev M.
8/13
04:16 pm
antx
Form 10-Q AN2 Therapeutics, Inc. For: Jun 30
Low
Report
Form 10-Q AN2 Therapeutics, Inc. For: Jun 30
8/13
04:07 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Aug 13
Medium
Report
Form 8-K AN2 Therapeutics, Inc. For: Aug 13
8/12
04:59 pm
antx
Form 3 AN2 Therapeutics, Inc. For: Aug 09 Filed by: Leonard Braden Michael
Medium
Report
Form 3 AN2 Therapeutics, Inc. For: Aug 09 Filed by: Leonard Braden Michael
8/12
04:48 pm
antx
Form SC 13G AN2 Therapeutics, Inc. Filed by: BML Investment Partners, L.P.
Medium
Report
Form SC 13G AN2 Therapeutics, Inc. Filed by: BML Investment Partners, L.P.
8/8
04:50 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Aug 07
High
Report
Form 8-K AN2 Therapeutics, Inc. For: Aug 07